Capio BiosciencesMar 131 minCapio Biosciences receives QNBV Certification from Wisconsin Economic Development Corporation (WEDC)Capio Biosciences is pleased to announce that they have received Qualified New Business Venture (QNBV) certification from WEDC. The QNBV program provides tax...
Capio BiosciencesJan 61 minCapio Biosciences Receives Notice of Allowance from Korean Intellectual Property OfficeCapio Biosciences is pleased to announce receipt of an official Notice of Allowance for patent application # 10-2017-7035887 - "Method for monitoring efficac...
Capio BiosciencesApr 11, 20191 minCapio Biosciences to present at the Liquid Biopsy Summit in San Francisco June 17-19th 2019Andrew Z. Wang, MD, CEO, Capio Biosciences will present "Capiocyte: A Highly Sensitive Circulating Tumor Cell Capture Assay for Improving Cancer Management"
Capio BiosciencesNov 1, 20181 minCapio Biosciences awarded an NIH SBIR grant effective August 1, 2018Capio Biosciences, an early stage biotechnology startup company developing a biopsy-free technology for capturing Circulating Tumor Cells (CTCs) and other ta...
Capio BiosciencesFeb 28, 20181 minCapio Biosciences technology featured in Nature MethodsBUILDING A MOLECULAR DIAGNOSTICS STARTUP FROM THE GROUND UP Download PDF
Capio BiosciencesDec 9, 20171 minFoxconn could take Wisconsin businesses to next levelSeungpyo Hong, founder of the cancer diagnostic company and Madison startup Capio Biosciences, said he met with executives from Foxconn recently and was hope...
Capio BiosciencesDec 9, 20171 minCancer Diagnostic Startup Capio Moves to Wisconsin, Raises $2.9MJeff Buchanan | January 5th, 2017 In certain patients who are being treated for cancer, it’s possible for cells to detach from the tumors inside their bodies...
Capio BiosciencesDec 9, 20171 minMadison draws a startup from Chicago with a novel way to track cancerby Judy Newman | Wisconsin State Journal | Dec 31, 2016 Madison draws a startup from Chicago with a novel way to track cancer Judy Newman | Wisconsin State...
Capio BiosciencesNov 20, 20171 minStart-up with UNC ties secures $2.9M to develop blood test for cancerA start-up company co-founded by UNC Lineberger researcher Andrew Wang, MD, has raised $2.9 million to commercialize a test designed to capture cancer cells ...
